KEAP1 and obesity disorder: Although the mechanisms by which β-cryptoxanthin prevents obesity have not been entirely clarified, it was suggested that β-cryptoxanthin might induce PPAR-α [36], antagonize PPAR-γ [37], and upregulate Keap1/Nrf2 pathway [38].